Urapidil Hydrochloride

Purui’s Urapidil Hydrochloride (CAS 64887-14-5) is a pharmaceutical-grade α-receptor blocker that meets USP, EP, and JP2017 standards. It exerts a dual antihypertensive effect by blocking peripheral α1 receptors and regulating the central nervous system, effectively lowering blood pressure without significant reflex tachycardia. As a trusted supplier, we offer Bulk Urapidil Hydrochloride procurement services and ensure Urapidil Hydrochloride for Sale with stable inventory, supporting both large-scale production of antihypertensive drugs and urgent clinical supply needs. Our product undergoes strict quality verification, with ultra-high purity and consistent performance to guarantee safety and efficacy in clinical applications.

Product Parameters (Specification)

Product Features and Applications

Product Features:

Dual antihypertensive mechanism: Combines peripheral vasodilation (α1 receptor blockage) and central blood pressure regulation, achieving gentle and sustained hypotensive effects with low incidence of adverse reactions;

Wide applicable population: Suitable for elderly patients, patients with chronic kidney disease, and those with hypertension combined with diabetes, with strong clinical adaptability;

Stable chemical properties: Resistant to oxidation and hydrolysis, ensuring consistent efficacy during long-term storage and formulation processing;

Global regulatory compliance: Meets multiple pharmacopoeia standards, facilitating the registration and marketing of finished products in global mainstream pharmaceutical markets.

Application Scenarios:

Hypertensive emergencies: Used for treating hypertensive crisis, hypertensive encephalopathy, and blood pressure spikes in patients with cerebral hemorrhage, rapidly stabilizing blood pressure to avoid organ damage;

Chronic hypertension: Core raw material for oral antihypertensive preparations (tablets, capsules), suitable for long-term control of mild to moderate hypertension;

Perioperative blood pressure management: Used for intraoperative and postoperative blood pressure regulation in cardiovascular surgery, neurosurgery, and other major surgeries;

Pharmaceutical formulation: Compatible with common excipients, supporting the development of injectable (intravenous infusion) and oral dosage forms to meet diverse clinical needs.

Procurement and Service Support

As your dedicated Urapidil Hydrochloride Supplier, we provide comprehensive and efficient procurement solutions:

Flexible Bulk Urapidil Hydrochloride supply: Competitive pricing based on order volume, with preferential policies for long-term cooperative pharmaceutical manufacturers;

Stable inventory guarantee: Urapidil Hydrochloride for Sale with sufficient stock, supporting immediate shipment and urgent order fulfillment to avoid production delays;

Professional documentation and logistics: Provide full sets of quality inspection reports (USP/EP/JP2017 compliant), certificate of analysis (COA), and regulatory registration materials; offer customized logistics plans (sea, air, land transportation) to ensure safe and timely delivery to domestic and international destinations;

Technical consultation support: Professional team offers guidance on formulation compatibility, solubility optimization, and storage precautions, helping customers solve application problems efficiently.

FAQ

Q1：What are the main clinical uses of Urapidil Hydrochloride?

A1：It is mainly used for the treatment of hypertension, including essential hypertension and severe hypertension, and also applied for blood pressure control during surgery.

Q2：What therapeutic advantages does Urapidil Hydrochloride have in cardiovascular application?

A2：It can steadily lower blood pressure without obvious reflex tachycardia, and is suitable for long-term blood pressure management in patients with cardiovascular complications.

Q3：What is the application of Urapidil Hydrochloride as a pharmaceutical intermediate?

A3：It serves as a key raw material for preparing finished antihypertensive preparations, and also used in pharmaceutical research and generic drug formulation development.